 FARMINGTON HILLS, Mich., Feb. 11, 2021 GLOBE NEWSWIRE -- Ocuphire Pharma, Inc. Nasdaq: OCUP, a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders, announced today that Mina Sooch, Chief Executive Officer will present a corporate overview at the 2021 BIO CEO Investor Conference and participate in select one-on-one investor meetings from February 16 to 18, 2021. Ocuphires management will also participate in Cantor Fitzgeralds Eyeing Key Events and Programs in the Ophthalmology Space in 2021 Panel on February 19, 2021 at 10:30am EST. 